News8Plus-Realtime Updates On Breaking News & Headlines

Realtime Updates On Breaking News & Headlines

India approves emergency use of Russian vaccine Sputnik-V, likely to get people from end of April

India has got a third vaccine amidst the havoc of the Corona virus released in the country. The Drug Controller General of India (DCGI) on Tuesday approved the use of a third corona vaccine, called Sputnik-V, made in Russia in emergency situations, after Kovishield and Kovacine on Tuesday. After this approval, Sputnik-V vaccine is expected to reach the common people by the end of April.

The Ministry of Health and Family Welfare said on Tuesday that the Drugs Controller General India (DCGI) has given its approval for the emergency use of the Russian vaccine Sputnik-V based on the recommendations of the Subject Expert Committee (SEC). “After detailed deliberations, the SEC has recommended allowing limited use of Sputnik-V in emergency situations subject to various regulatory provisions,” the ministry said in a statement.

The Ministry stated that Sputnik-V vaccine should be given intramuscularly with two doses of 0.5 ml at an interval of 21 days. The Ministry also stated that the vaccine is to be stored at -18 ° C. The Ministry clarified that the recommendations of the SEC have been accepted by the Drug Controller of India after careful consideration and stated that Dr. Reddy’s Laboratories Limited (DRL) will import the vaccine for use in the country.

Explain that Dr. Reddy’s Laboratories played an important role in September 2020 in partnership with the Russian Direct Investment Fund (RDIF) to conduct clinical trials of the Sputnik vaccine and distribute the vaccine in India. In addition to the tests conducted by RDIF in Russia, Dr. Reddy’s also played a role in the clinical trials of phase two and three of the vaccine in India.

Significantly, a nationwide vaccination campaign has started in India from January 16 this year. At this time, the use of Bharat Biotech’s Covaxin and Serum Institute of India’s Kovishield was approved in the country. India’s drug regulator has now approved the limited emergency use of Russia’s Kovid-19 vaccine Sputnik-V with some conditions. Now, after the approval of the third vaccine, the possibility of further increase in the vaccination campaign in the coming days has also been strengthened. Not only this, many other vaccines are also in various stages of clinical development within the country.


If you have any concerns or complaints regarding this article, please let us know and the article will be removed soon. 

Raise A Concern